Caution in interpretation of abnormal carbon monoxide diffusion capacity in covid-19 patients
Type
Article, LetterDate
2021Funding information
AstraZeneca GlaxoSmithKline, GSK Boehringer Ingelheim National Health and Medical Research Council, NHMRC GlaxoSmithKline Australia, GSK
Licence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and HealthShare